Akay M, Sener K, Sari S, Bodur E
Protein J. 2025; .
PMID: 39987389
DOI: 10.1007/s10930-025-10259-8.
Liu C, Guo Y, Zhang X, Chen H, Han M, Wang H
Front Vet Sci. 2025; 11:1526705.
PMID: 39916965
PMC: 11799562.
DOI: 10.3389/fvets.2024.1526705.
Xie S, Miao X, Li G, Zheng Y, Li M, Ji E
bioRxiv. 2025; .
PMID: 39763957
PMC: 11703214.
DOI: 10.1101/2024.12.22.627112.
Silva B, Lima J, Echeverry M, Alberto-Silva C
Neurol Int. 2024; 16(6):1731-1741.
PMID: 39728751
PMC: 11678777.
DOI: 10.3390/neurolint16060125.
Schmidt S, Heinrich M, Wernecke K, Spies C, Hancke L, Mueller A
Intensive Care Med Exp. 2024; 12(1):120.
PMID: 39715945
PMC: 11666856.
DOI: 10.1186/s40635-024-00709-5.
Shifts in the spatiotemporal profile of inflammatory phenotypes of innate immune cells in the rat brain following acute intoxication with the organophosphate diisopropylfluorophosphate.
Andrew P, MacMahon J, Bernardino P, Tsai Y, Hobson B, Porter V
J Neuroinflammation. 2024; 21(1):285.
PMID: 39497181
PMC: 11533402.
DOI: 10.1186/s12974-024-03272-8.
Effects of Free and Nanoencapsulated Benznidazole in Acute Infection: Role of Cholinergic Pathway and Redox Status.
da Silva A, Fracasso M, Bottari N, Palma T, Engelmann A, Castro M
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39459036
PMC: 11510717.
DOI: 10.3390/ph17101397.
Repurposing of USFDA-approved drugs to identify leads for inhibition of acetylcholinesterase enzyme: a plausible utility as an anti-Alzheimer agent.
Goel K, Chahal S, Kumar D, Jaiswal S, Nainwal N, Singh R
RSC Med Chem. 2024; .
PMID: 39371435
PMC: 11447705.
DOI: 10.1039/d4md00461b.
Preliminary exploration of the expression of acetylcholinesterase in normal human T lymphocytes and leukemic Jurkat T cells.
Gomez-Olivares J, Lopez-Duran R, Enriquez-Flores S, Lopez-Velazquez G, de la Mora-de la Mora I, Garcia-Torres I
Biomed Rep. 2024; 21(5):158.
PMID: 39268406
PMC: 11391169.
DOI: 10.3892/br.2024.1846.
Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets.
Yates J
Subst Abuse Rehabil. 2024; 15:125-161.
PMID: 39228432
PMC: 11370775.
DOI: 10.2147/SAR.S431273.
A second hit by PFOS exposure exacerbated developmental defects in medaka embryos with a history of ancestral BPA exposure.
Coe S, Chakraborty S, Faheem M, Kupradit K, Bhandari R
Chemosphere. 2024; 362:142796.
PMID: 38972462
PMC: 11309894.
DOI: 10.1016/j.chemosphere.2024.142796.
Rodent Models of Alzheimer's Disease: Past Misconceptions and Future Prospects.
Collins H, Greenfield S
Int J Mol Sci. 2024; 25(11).
PMID: 38892408
PMC: 11172947.
DOI: 10.3390/ijms25116222.
Amyloid Beta Leads to Decreased Acetylcholine Levels and Non-Small Cell Lung Cancer Cell Survival via a Mechanism That Involves p38 Mitogen-Activated Protein Kinase and Protein Kinase C in a p53-Dependent and -Independent Manner.
Al Khashali H, Ray R, Darweesh B, Wozniak C, Haddad B, Goel S
Int J Mol Sci. 2024; 25(9).
PMID: 38732252
PMC: 11084752.
DOI: 10.3390/ijms25095033.
New Charged Cholinesterase Inhibitors: Design, Synthesis, and Characterization.
Mlakic M, Baric D, Ratkovic A, Sagud I, cipor I, Piantanida I
Molecules. 2024; 29(7).
PMID: 38611900
PMC: 11013433.
DOI: 10.3390/molecules29071622.
Transport mechanism of presynaptic high-affinity choline uptake by CHT1.
Qiu Y, Gao Y, Huang B, Bai Q, Zhao Y
Nat Struct Mol Biol. 2024; 31(4):701-709.
PMID: 38589607
DOI: 10.1038/s41594-024-01259-w.
Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
Pathak K, Ahmad M, Saikia R, Pathak M, Sahariah J, Kalita P
Cent Nerv Syst Agents Med Chem. 2024; 25(1):3-19.
PMID: 38551038
DOI: 10.2174/0118715249281331240325042642.
Sequential Contrastive and Deep Learning Models to Identify Selective Butyrylcholinesterase Inhibitors.
Ozalp M, Vignaux P, Puhl A, Lane T, Urbina F, Ekins S
J Chem Inf Model. 2024; 64(8):3161-3172.
PMID: 38532612
PMC: 11331448.
DOI: 10.1021/acs.jcim.4c00397.
The Role of G Protein-Coupled Receptors and Receptor Kinases in Pancreatic -Cell Function and Diabetes.
Varney M, Benovic J
Pharmacol Rev. 2024; 76(2):267-299.
PMID: 38351071
PMC: 10877731.
DOI: 10.1124/pharmrev.123.001015.
Organophosphate Detoxification and Acetylcholinesterase Reactivation Triggered by Zeolitic Imidazolate Framework Structural Degradation.
Martin-Romera J, Borrego-Marin E, Jabalera-Ortiz P, Carraro F, Falcaro P, Barea E
ACS Appl Mater Interfaces. 2024; 16(8):9900-9907.
PMID: 38344949
PMC: 10910433.
DOI: 10.1021/acsami.3c18855.
Targeting Alzheimer's Disease: Evaluating the Efficacy of C-1 Functionalized N-Aryl-Tetrahydroisoquinolines as Cholinergic Enzyme Inhibitors and Promising Therapeutic Candidates.
Jovanovic D, Filipovic A, Janjic G, Lazarevic-Pasti T, Dzambaski Z, Bondzic B
Int J Mol Sci. 2024; 25(2).
PMID: 38256107
PMC: 10816625.
DOI: 10.3390/ijms25021033.